SERPINA1 and metabolic dysfunction-associated steatotic liver disease: In the previous study, we comprehensively analysed N-glycans of serum glycoproteins in NAFLD patients using the FPG method and found that AAT-A3F could be a useful biomarker for NASH diagnosis.